246 related articles for article (PubMed ID: 36764729)
1. Subcutaneous fast-acting insulin analogues, alone or in combination with long-acting insulin, versus intravenous regular insulin infusion in patients with diabetic ketoacidosis: protocol for an updated systematic review and meta-analysis of randomised trials.
Lim BL; Lee WF; Lee B; Chung YEL; Loo KV
BMJ Open; 2023 Feb; 13(2):e070131. PubMed ID: 36764729
[TBL] [Abstract][Full Text] [Related]
2. Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis.
Andrade-Castellanos CA; Colunga-Lozano LE; Delgado-Figueroa N; Gonzalez-Padilla DA
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011281. PubMed ID: 26798030
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
Pala L; Dicembrini I; Mannucci E
Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
[TBL] [Abstract][Full Text] [Related]
5. Benefits and safety of transdermal glyceryl trinitrate in acute stroke: a systematic review and meta-analysis of randomised trials (protocol).
Lim BL; Lee WF; Ng WM; Tay WL; Chan WL
BMJ Open; 2021 Jan; 11(1):e043591. PubMed ID: 33402412
[TBL] [Abstract][Full Text] [Related]
6. (Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus.
Hemmingsen B; Metzendorf MI; Richter B
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013498. PubMed ID: 33662147
[TBL] [Abstract][Full Text] [Related]
7. Does Management of Diabetic Ketoacidosis with Subcutaneous Rapid-acting Insulin Reduce the Need for Intensive Care Unit Admission?
Cohn BG; Keim SM; Watkins JW; Camargo CA
J Emerg Med; 2015 Oct; 49(4):530-8. PubMed ID: 26238182
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous regular insulin for the treatment of diabetic ketoacidosis in children.
Cohen M; Leibovitz N; Shilo S; Zuckerman-Levin N; Shavit I; Shehadeh N
Pediatr Diabetes; 2017 Jun; 18(4):290-296. PubMed ID: 27005007
[TBL] [Abstract][Full Text] [Related]
9. Subcutaneous Insulin Versus Traditional Intravenous Insulin Infusion in Treatment of Mild to Moderate Diabetic Ketoacidosis.
Stuhr K; LeeMaster R; Hickman AW; Reachi B; Pace W; Meek C
J Emerg Med; 2023 Sep; 65(3):e221-e228. PubMed ID: 37689412
[TBL] [Abstract][Full Text] [Related]
10. Treatment of diabetic ketoacidosis with subcutaneous insulin lispro: a review of the current evidence from clinical studies.
Vincent M; Nobécourt E
Diabetes Metab; 2013 Sep; 39(4):299-305. PubMed ID: 23642642
[TBL] [Abstract][Full Text] [Related]
11. Safety, effectiveness, and cost of long-acting versus intermediate-acting insulin for type 1 diabetes: protocol for a systematic review and network meta-analysis.
Tricco AC; Ashoor HM; Soobiah C; Hemmelgarn B; Moher D; Hutton B; Yu CH; Majumdar SR; Straus SE
Syst Rev; 2013 Sep; 2():73. PubMed ID: 24020869
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Commonly Used Insulin Analogues in the Treatment of Diabetic Ketoacidosis: A Bayesian Indirect Treatment Comparison.
Vidyasagar K; Chandrasekar B; Chhabra M; Bhansali A; Bansal D
Clin Ther; 2020 Aug; 42(8):e115-e139. PubMed ID: 32798057
[TBL] [Abstract][Full Text] [Related]
13. Comparison of subcutaneous insulin aspart and intravenous regular insulin for the treatment of mild and moderate diabetic ketoacidosis in pediatric patients.
Razavi Z; Maher S; Fredmal J
Endocrine; 2018 Aug; 61(2):267-274. PubMed ID: 29797212
[TBL] [Abstract][Full Text] [Related]
14. Short-acting insulin analogues versus regular human insulin for adult, non-pregnant persons with type 2 diabetes mellitus.
Fullerton B; Siebenhofer A; Jeitler K; Horvath K; Semlitsch T; Berghold A; Gerlach FM
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD013228. PubMed ID: 30556900
[TBL] [Abstract][Full Text] [Related]
15. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus.
Siebenhofer A; Plank J; Berghold A; Narath M; Gfrerer R; Pieber TR
Cochrane Database Syst Rev; 2004 Oct; (4):CD003287. PubMed ID: 15495047
[TBL] [Abstract][Full Text] [Related]
16. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus.
Siebenhofer A; Plank J; Berghold A; Narath M; Gfrerer R; Pieber TR
Cochrane Database Syst Rev; 2004; (2):CD003287. PubMed ID: 15106199
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis.
Umpierrez GE; Latif K; Stoever J; Cuervo R; Park L; Freire AX; E Kitabchi A
Am J Med; 2004 Sep; 117(5):291-6. PubMed ID: 15336577
[TBL] [Abstract][Full Text] [Related]
18. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
[TBL] [Abstract][Full Text] [Related]
19. Insulin analogs versus human insulin in the treatment of patients with diabetic ketoacidosis: a randomized controlled trial.
Umpierrez GE; Jones S; Smiley D; Mulligan P; Keyler T; Temponi A; Semakula C; Umpierrez D; Peng L; Cerón M; Robalino G
Diabetes Care; 2009 Jul; 32(7):1164-9. PubMed ID: 19366972
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections on glycaemic control among older adults with type 2 diabetes: protocol for systematic review and meta-analysis.
Yang B; Han L; Wang Y; Cheng K
BMJ Open; 2023 Jan; 13(1):e063161. PubMed ID: 36631237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
